Literature DB >> 18758693

Multinodular goiter and primary hyperparathyroidism: a circuitous route to diagnosing metastatic uveal melanoma.

Constantine G A Theoharis1, Tobias Carling, Natalia Buza, Eduardo Zambrano, Julie Ann Sosa.   

Abstract

Uveal melanoma spreads exclusively via a hematogenous route and is notable for its latency. Liver metastases are common; however, metastatic spread to unusual sites has been encountered. We report the case of metastatic uveal melanoma in a woman with multinodular goiter and primary hyperparathyroidism. The patient presented with hypercalcemia and an elevated intact parathyroid hormone level, in conjunction with a follicular neoplasm in the setting of goiter. She underwent an uneventful total thyroidectomy and parathyroidectomy. Postoperatively, she became normocalcemic. Histopathologic analyses revealed metastatic uveal melanoma cells within both the multinodular goiter and parathyroid adenoma. At present, she is enrolled in a phase II trial for disseminated uveal melanoma. This is a report of uveal melanoma metastatic to both a parathyroid adenoma and a nodular hyperplastic thyroid. Additionally, this case serves to display the unusual metastatic potential of uveal melanoma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18758693     DOI: 10.1007/s12022-008-9041-3

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  15 in total

1.  A randomized phase II trial of gemcitabine plus treosulfan versus treosulfan alone in patients with metastatic uveal melanoma.

Authors:  A Schmittel; M Schmidt-Hieber; P Martus; N E Bechrakis; R Schuster; J M Siehl; M H Foerster; E Thiel; U Keilholz
Journal:  Ann Oncol       Date:  2006-09-13       Impact factor: 32.976

Review 2.  Current approaches in the management of uveal melanomas.

Authors:  E S Gragoudas
Journal:  Int Ophthalmol Clin       Date:  1992

3.  Time to systemic metastases in patients with posterior uveal melanoma.

Authors:  T Sato; A Babazono; J A Shields; C L Shields; P De Potter; M J Mastrangelo
Journal:  Cancer Invest       Date:  1997       Impact factor: 2.176

4.  Clinical and cytogenetic analyses in uveal melanoma.

Authors:  Emine Kilic; Walter van Gils; Elisabeth Lodder; H Berna Beverloo; Marjan E van Til; Cornelia M Mooy; Dion Paridaens; Annelies de Klein; Gregorius P M Luyten
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-09       Impact factor: 4.799

5.  Tumor-to-tumor metastasis: malignant melanoma metastatic to parathyroid adenoma.

Authors:  T Inoshita; A R Laurain
Journal:  Mil Med       Date:  1985-06       Impact factor: 1.437

6.  Metastatic ocular and cutaneous melanoma: a comparison of patient characteristics and prognosis.

Authors:  D M Albert; L M Ryan; E C Borden
Journal:  Arch Ophthalmol       Date:  1996-01

7.  Occult thyroid metastasis from untreated uveal melanoma.

Authors:  G Gherardi; P Scherini; S Ambrosi
Journal:  Arch Ophthalmol       Date:  1985-05

8.  Post-menopausal bleeding: a rare presentation of metastatic uveal melanoma.

Authors:  Michael A Coutts; Nicola J Borthwick; John L Hungerford; Ian A Cree
Journal:  Pathol Oncol Res       Date:  2006-09-23       Impact factor: 3.201

9.  Hepatic metastasis and orbital recurrence of uveal melanoma after 42 years.

Authors:  J A Shields; J J Augsburger; L A Donoso; V B Bernardino; M Portenar
Journal:  Am J Ophthalmol       Date:  1985-11-15       Impact factor: 5.258

10.  Clinically significant, isolated metastatic disease to the thyroid gland.

Authors:  H Chen; T L Nicol; R Udelsman
Journal:  World J Surg       Date:  1999-02       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.